Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
INSERM UMR 1170, |
RCV000190403 | SCV000224007 | likely pathogenic | Thrombocythemia 1 | 2015-06-01 | criteria provided, single submitter | research | overexpression of ATG2B and GSKIP enhance hematopoietic progenitor differentiation |
INSERM UMR 1170, |
RCV000190404 | SCV000224008 | likely pathogenic | Primary myelofibrosis | 2015-06-01 | criteria provided, single submitter | research | overexpression of ATG2B and GSKIP enhance hematopoietic progenitor differentiation |
INSERM UMR 1170, |
RCV000190405 | SCV000224009 | likely pathogenic | Acute myeloid leukemia | 2015-06-01 | criteria provided, single submitter | research | overexpression of ATG2B and GSKIP enhance hematopoietic progenitor differentiation |
INSERM UMR 1170, |
RCV000190406 | SCV000224010 | likely pathogenic | Thrombocythemia 1; Acute myeloid leukemia | 2015-06-01 | criteria provided, single submitter | research | overexpression of ATG2B and GSKIP enhance hematopoietic progenitor differentiation |